Stock Incentive Plan - Schedule of Information Regarding Restricted Stock Activity (Detail) - USD ($) |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2020 |
Dec. 31, 2019 |
|
| Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||
| Outstanding Shares, Beginning Balance | 107,990 | |
| Outstanding Shares, Ending Balance | 107,990 | 107,990 |
| Weighted Average Grant Date Fair Value, Beginning Balance | $ 1.85 | |
| Weighted Average Grant Date Fair Value, Ending Balance | $ 1.85 | $ 1.85 |
| Weighted Average Contractual Life Remaining | 1 year 5 months 1 day | 1 year 8 months 1 day |
| Aggregate Intrinsic Value, Beginning Balance | $ 156 | |
| Aggregate Intrinsic Value, Ending Balance | $ 93 | $ 156 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|